EUVIMEDEUVIMED entdecken
Crossref

Acute Large Dose Irradiation Sensitizes Surviving Cells to Subsequent Irradiation; Implications for Stereotactic Body Radiation Therapy

Yaotiao Deng, Xingchen Peng, Leo E Gerweck

Radiation Research · 08.03.2024 · 201 (3) · 261-266

DOI: 10.1667/rade-22-00166.1 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Radiation Research, erschienen am 08.03.2024. Verfasst von Yaotiao Deng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Massachusetts General Hospital, Boston Massachusetts 02144. Hauptthemen laut MEDLINE: Radiosurgery. Die Arbeit nennt 24 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To determine if the radiation sensitivity of cells that survive acute high-dose radiation exposure used in stereotactic body radiation therapy (SBRT), differs from the sensitivity of non-irradiated cells and cells that survive multiple 2 Gy doses of radiation. Isogenic rodent and two human tumor cell lines were exposed to 14 × 2 Gy of radiation, or a single acute dose of 12 Gy. The most resistant cell line was also exposed to an acute dose of 15 Gy. One week after 12 Gy, and 4 days after 14 × 2 Gy, surviving cells were exposed to 0–8 Gy in 2 Gy doses and cell survival was assessed by colony formation. In addition, the colony forming efficiency of 12 Gy survivors was evaluated for 1 month postirradiation. For cells exposed to 15 Gy, the response of surviving cells to 6 Gy was determined for up to 35 days postirradiation and compared to the 6 Gy surviving fraction of control cells. The radiation sensitivity of cells that survived 12 Gy exposure, and cells that survived 14 fractions of 2 Gy irradiation did not differ from the response of unirradiated control cells. However, the growth rate and colony forming efficiency of 12 Gy survivors was transiently reduced for greater than 2 weeks postirradiation. In contrast to the unchanged sensitivity of 12 Gy surviving cells at day 7 postirradiation, 15 Gy survivors exhibited enhanced sensitivity to radiation for up to 21 days postirradiation and suggests a biological basis for SBRT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RadiosurgeryHumansRadiation DosageRadiation ToleranceCell SurvivalDose-Response Relationship, Radiation

Autor:innen und Institutionen

  • Department of Radiation Oncology, Massachusetts General Hospital, Boston Massachusetts 02144.

Zitieren

APA

Deng, Y., Peng, X., & Gerweck, L. E. (2024). Acute Large Dose Irradiation Sensitizes Surviving Cells to Subsequent Irradiation; Implications for Stereotactic Body Radiation Therapy. Radiation Research, 201(3), 261-266. https://doi.org/10.1667/rade-22-00166.1

Vancouver

Deng Y, Peng X, Gerweck LE. Acute Large Dose Irradiation Sensitizes Surviving Cells to Subsequent Irradiation; Implications for Stereotactic Body Radiation Therapy. Radiation Research. 2024;201(3):261-266. doi:10.1667/rade-22-00166.1

BibTeX
@article{Deng2024,
  author = {Deng, Yaotiao and Peng, Xingchen and Gerweck, Leo E},
  title = {Acute Large Dose Irradiation Sensitizes Surviving Cells to Subsequent Irradiation; Implications for Stereotactic Body Radiation Therapy},
  journal = {Radiation Research},
  year = {2024},
  volume = {201},
  number = {3},
  pages = {261--266},
  doi = {10.1667/rade-22-00166.1}
}
Kostenlos starten →